In vitro delivery, cytotoxicity, swelling, and degradation behavior of a liquid-to-solid gelling polymer system for cerebral aneurysm embolization

Celeste R. Brennecka, Mark C. Preul, Brent Vernon

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

This study examines the in vitro characteristics of a crosslinking polymer system for cerebral aneurysm embolization. The polymeric material is composed of poly(propylene glycol)diacrylate (PPODA) and pentaerythritol tetrakis(3-mercaptopropionate) (QT), formulated with the liquid contrast agents Conray™ or Omnipaque™ 300. The PPODA-QT system was tested for delivery feasibility through mock delivery into a model aneurysm. Cytotoxicity was performed by exposing 3T3 cells to gel formulations, followed by a cell viability assay. Swelling was measured on samples submerged in 150 mM phosphate buffered saline at 37 or 50°C. The same samples underwent compression testing to assess degradation, characterized by reduction in Young's modulus over time. The PPODA-QT system was easily deliverable to mock aneurysms. Cytotoxicity results indicated that Conray-formulated gels are initially less toxic than Omnipaqueformulated gels, but show greater susceptibility to swelling and degradation over time. In general, these experiments represented more challenging conditions than would be present in vivo, and therefore, reported results are likely overestimations of in vivo outcomes. However, these results highlight potential issues with each PPODA-QT formulation. Given the desired outcome of neointimal tissue growth over the polymer material, initial cytotoxicity may be more important than longterm factors when choosing an optimal formulation for aneurysm embolization.

Original languageEnglish (US)
Pages (from-to)1298-1309
Number of pages12
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume100 B
Issue number5
DOIs
StatePublished - Jul 2012

Fingerprint

Cytotoxicity
Swelling
Polymers
Gels
Degradation
Liquids
Iohexol
Compression testing
Propylene Glycol
Poisons
Glycols
Crosslinking
Contrast Media
Propylene
Assays
Phosphates
Elastic moduli
Cells
Tissue
Experiments

Keywords

  • Cerebral aneurysm
  • Cytotoxicity
  • Degradation
  • Embolization
  • In vitro

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

@article{e1d1f9ca920a410b8388282bec4d8c52,
title = "In vitro delivery, cytotoxicity, swelling, and degradation behavior of a liquid-to-solid gelling polymer system for cerebral aneurysm embolization",
abstract = "This study examines the in vitro characteristics of a crosslinking polymer system for cerebral aneurysm embolization. The polymeric material is composed of poly(propylene glycol)diacrylate (PPODA) and pentaerythritol tetrakis(3-mercaptopropionate) (QT), formulated with the liquid contrast agents Conray™ or Omnipaque™ 300. The PPODA-QT system was tested for delivery feasibility through mock delivery into a model aneurysm. Cytotoxicity was performed by exposing 3T3 cells to gel formulations, followed by a cell viability assay. Swelling was measured on samples submerged in 150 mM phosphate buffered saline at 37 or 50°C. The same samples underwent compression testing to assess degradation, characterized by reduction in Young's modulus over time. The PPODA-QT system was easily deliverable to mock aneurysms. Cytotoxicity results indicated that Conray-formulated gels are initially less toxic than Omnipaqueformulated gels, but show greater susceptibility to swelling and degradation over time. In general, these experiments represented more challenging conditions than would be present in vivo, and therefore, reported results are likely overestimations of in vivo outcomes. However, these results highlight potential issues with each PPODA-QT formulation. Given the desired outcome of neointimal tissue growth over the polymer material, initial cytotoxicity may be more important than longterm factors when choosing an optimal formulation for aneurysm embolization.",
keywords = "Cerebral aneurysm, Cytotoxicity, Degradation, Embolization, In vitro",
author = "Brennecka, {Celeste R.} and Preul, {Mark C.} and Brent Vernon",
year = "2012",
month = "7",
doi = "10.1002/jbm.b.32696",
language = "English (US)",
volume = "100 B",
pages = "1298--1309",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "0021-9304",
publisher = "Heterocorporation",
number = "5",

}

TY - JOUR

T1 - In vitro delivery, cytotoxicity, swelling, and degradation behavior of a liquid-to-solid gelling polymer system for cerebral aneurysm embolization

AU - Brennecka, Celeste R.

AU - Preul, Mark C.

AU - Vernon, Brent

PY - 2012/7

Y1 - 2012/7

N2 - This study examines the in vitro characteristics of a crosslinking polymer system for cerebral aneurysm embolization. The polymeric material is composed of poly(propylene glycol)diacrylate (PPODA) and pentaerythritol tetrakis(3-mercaptopropionate) (QT), formulated with the liquid contrast agents Conray™ or Omnipaque™ 300. The PPODA-QT system was tested for delivery feasibility through mock delivery into a model aneurysm. Cytotoxicity was performed by exposing 3T3 cells to gel formulations, followed by a cell viability assay. Swelling was measured on samples submerged in 150 mM phosphate buffered saline at 37 or 50°C. The same samples underwent compression testing to assess degradation, characterized by reduction in Young's modulus over time. The PPODA-QT system was easily deliverable to mock aneurysms. Cytotoxicity results indicated that Conray-formulated gels are initially less toxic than Omnipaqueformulated gels, but show greater susceptibility to swelling and degradation over time. In general, these experiments represented more challenging conditions than would be present in vivo, and therefore, reported results are likely overestimations of in vivo outcomes. However, these results highlight potential issues with each PPODA-QT formulation. Given the desired outcome of neointimal tissue growth over the polymer material, initial cytotoxicity may be more important than longterm factors when choosing an optimal formulation for aneurysm embolization.

AB - This study examines the in vitro characteristics of a crosslinking polymer system for cerebral aneurysm embolization. The polymeric material is composed of poly(propylene glycol)diacrylate (PPODA) and pentaerythritol tetrakis(3-mercaptopropionate) (QT), formulated with the liquid contrast agents Conray™ or Omnipaque™ 300. The PPODA-QT system was tested for delivery feasibility through mock delivery into a model aneurysm. Cytotoxicity was performed by exposing 3T3 cells to gel formulations, followed by a cell viability assay. Swelling was measured on samples submerged in 150 mM phosphate buffered saline at 37 or 50°C. The same samples underwent compression testing to assess degradation, characterized by reduction in Young's modulus over time. The PPODA-QT system was easily deliverable to mock aneurysms. Cytotoxicity results indicated that Conray-formulated gels are initially less toxic than Omnipaqueformulated gels, but show greater susceptibility to swelling and degradation over time. In general, these experiments represented more challenging conditions than would be present in vivo, and therefore, reported results are likely overestimations of in vivo outcomes. However, these results highlight potential issues with each PPODA-QT formulation. Given the desired outcome of neointimal tissue growth over the polymer material, initial cytotoxicity may be more important than longterm factors when choosing an optimal formulation for aneurysm embolization.

KW - Cerebral aneurysm

KW - Cytotoxicity

KW - Degradation

KW - Embolization

KW - In vitro

UR - http://www.scopus.com/inward/record.url?scp=84862231226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862231226&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.32696

DO - 10.1002/jbm.b.32696

M3 - Article

C2 - 22514032

AN - SCOPUS:84862231226

VL - 100 B

SP - 1298

EP - 1309

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 0021-9304

IS - 5

ER -